Literature DB >> 22784041

Preexposure prophylaxis for HIV--where do we go from here?

Myron S Cohen, Lindsey R Baden.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22784041     DOI: 10.1056/NEJMe1207438

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

Review 1.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

2.  Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion.

Authors:  Tiara Willie; Trace Kershaw; Jacquelyn C Campbell; Kamila A Alexander
Journal:  AIDS Behav       Date:  2017-08

3.  Inefficient vaginal transmission of tenofovir-resistant HIV-1.

Authors:  Morgan Chateau; Michael D Swanson; J Victor Garcia
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 4.  State of condom use in HIV prevention science and practice.

Authors:  Richard A Crosby
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

5.  Medicinal chemistry: Forcing an enemy into the open.

Authors:  Christian Melander; David M Margolis
Journal:  Nat Chem       Date:  2012-09       Impact factor: 24.427

Review 6.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

7.  Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Authors:  Elisa F Long; Robert R Stavert
Journal:  J Gen Intern Med       Date:  2013-04-16       Impact factor: 5.128

8.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02

Review 9.  Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 10.  The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.

Authors:  Stefan D Baral; Susanne Strömdahl; Chris Beyrer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.